BCPC BALCHEM CORP
Chemicals & Allied Products · Nasdaq · SEC CIK 9326 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY14.5%
TTM EPS YoY16.2%
Revenue 3-yr CAGR6.2%
Net income 3-yr CAGR18.3%
Margins
Gross margin36.5%
Operating margin20.7%
Net margin15.4%
FCF margin—
EBITDA margin25.1%
Returns
ROE13.0%
ROA10.2%
ROIC (approx.)14.3%
Asset turnover0.66x
Leverage & solvency
Liabilities / assets22.1%
Debt / equity0.00x
Current ratio2.47x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.31x
Accruals ratio-3.1%
Payout ratio18.0%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q42025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q42024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $290.66M | $284.00M | $270.71M | $263.62M | $267.56M | $255.47M | $250.52M | $240.00M |
| Cost of revenue | $184.94M | $180.31M | $169.62M | $169.72M | $172.10M | $162.35M | $162.35M | $153.67M |
| Gross profit | $105.71M | $103.68M | $101.08M | $93.90M | $95.45M | $93.11M | $88.17M | $86.34M |
| R&D expense | $5.34M | $4.53M | $5.88M | $5.05M | $4.50M | $4.30M | $4.66M | $4.51M |
| SG&A expense | $17.24M | $18.79M | $18.48M | $16.50M | $17.29M | $18.07M | $15.56M | $17.27M |
| Operating income | $62.44M | $59.22M | $55.63M | $52.29M | $54.58M | $51.44M | $51.02M | $47.44M |
| Pretax income | $60.04M | $57.78M | $52.52M | $50.03M | $52.04M | $49.01M | $47.94M | $44.48M |
| Income tax | $13.32M | $13.17M | $12.24M | $10.81M | $11.76M | $10.73M | $10.89M | $10.90M |
| Net income | $46.73M | $44.62M | $40.28M | $39.23M | $40.29M | $38.28M | $37.05M | $33.58M |
| EBITDA | $74.83M | $71.44M | $68.12M | $64.01M | $66.13M | $62.84M | $62.03M | $58.34M |
| EPS (basic) | 1.47 | 1.40 | 1.26 | 1.23 | 1.25 | 1.18 | 1.14 | 1.05 |
| EPS (diluted) | 1.46 | 1.39 | 1.25 | 1.21 | 1.24 | 1.17 | 1.13 | 1.03 |
| Weighted avg. shares (diluted) | 32.03M | 32.20M | 32.28M | — | 32.59M | 32.68M | 32.81M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $66.26M | $63.17M | $72.87M | $74.57M | $65.09M | $65.43M | $49.90M | $49.52M |
| Receivables | $145.63M | $148.97M | $154.23M | $143.60M | $131.54M | $135.98M | $130.45M | $119.66M |
| Inventory | $177.01M | $161.55M | $146.74M | $131.45M | $132.44M | $148.15M | $144.93M | $130.80M |
| Current assets | $404.88M | $388.42M | $388.94M | $365.61M | $343.71M | $364.86M | $340.24M | $313.77M |
| PP&E, net | $306.13M | $304.70M | $303.07M | $306.65M | $297.84M | $290.09M | $283.75M | $282.15M |
| Goodwill | $807.49M | $808.81M | $811.45M | $816.38M | $816.49M | $816.39M | $793.09M | $780.03M |
| Intangibles | $120.08M | $123.73M | $127.68M | $132.99M | $136.13M | $139.35M | $165.97M | $132.48M |
| Total assets | $1.70B | $1.69B | $1.69B | $1.69B | $1.66B | $1.68B | $1.62B | $1.58B |
| Current liabilities | $164.12M | $145.75M | $152.54M | $176.38M | $126.37M | $138.14M | $139.56M | $157.69M |
| Total liabilities | $376.80M | $384.63M | $408.63M | $428.84M | $363.17M | $410.33M | $408.85M | $425.46M |
| Shareholders' equity | $1.33B | $1.30B | $1.29B | $1.26B | $1.30B | $1.27B | $1.21B | $1.15B |
| Shares outstanding | 31.82M | 31.96M | 32.13M | 32.06M | 32.38M | 32.46M | 32.61M | 32.53M |
| Cash flow statement | ||||||||
| Operating cash flow | $69.77M | $46.71M | $40.06M | $67.28M | $65.57M | $47.25M | $36.46M | $52.32M |
| Investing cash flow | -$12.53M | -$10.93M | -$6.29M | -$16.42M | -$14.94M | -$6.62M | -$5.91M | -$36.96M |
| Financing cash flow | -$53.59M | -$44.83M | -$34.78M | -$41.25M | -$50.83M | -$28.76M | -$31.97M | -$35.21M |
| Depreciation & amortization | $12.39M | $12.22M | $12.49M | $11.72M | $11.55M | $11.40M | $11.01M | $10.90M |
| Stock-based compensation | $5.04M | $5.92M | $5.36M | $3.76M | $4.65M | $5.84M | $3.81M | $3.89M |
| Dividends paid | $1,000 | $3,000 | $30.77M | $11,000 | $11,000 | $2,000 | $28.26M | $4,000 |
| Share buybacks | $27.44M | $28.79M | $15.69M | $53.63M | $15.42M | $33.26M | $5.33M | $306,000 |
Free plan shows the latest 8 periods; Pro shows all 67 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.